Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon

BACKGROUND AND AIM: The durability of the sustained virologic response (SVR) in patients with chronic hepatitis C after treatment and the ideal follow-up time for these patients remains undefined. The objective of the study was to evaluate the durability of the virologic response in patients with ch...

Full description

Bibliographic Details
Main Authors:	Sandro da Costa Ferreira, Marcos de Vasconcelos Carneiro, Fernanda Fernandes Souza, Andreza Corrêa Teixeira, Marcia Guimarães Villanova, José Fernando de Castro Figueiredo, Afonso Dinis Costa Passos, Leandra Naira Zambelli Ramalho, Sergio Zucoloto, Ana de Lourdes Candolo Martinelli
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	hepatitis C interferon HCV follow-up hepatocellular carcinoma
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000400003&lng=en&tlng=en

Similar Items

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon
by: Sandro da Costa Ferreira, MD, et al.
Published: (2010-07-01)

HCV virological response during treatment of chronic hepatitis C is associated with liver histological Improvement in patients with HCV/HIV co-infection
by: Gleusa Castro, et al.

The evolving role of interferons in viral eradication strategies
by: Tomas Doyle
Published: (2016-04-01)

Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis
by: Amira Youssef Shaala, et al.
Published: (2015-09-01)

Impact of Interferon-Based Therapy on Hepatitis C-Associated Rheumatic Diseases: A Nationwide Population-Based Cohort Study
by: Jur-Shan Cheng, et al.
Published: (2021-02-01)

Are anti-interferon antibodies the cause of failure in: chronic HCV hepatitis treatment?
by: Antonio Alci Barone, et al.

Interferon α therapy in patients with chronic hepatitis C infection: quality of life and depression
by: Ciro Conversano, et al.
Published: (2015-03-01)

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals
by: Vogel M, et al.
Published: (2010-03-01)

Anti-diabetic drugs, insulin and metformin, have no direct interaction with hepatitis C virus infection or anti-viral interferon response
by: Mohamad S. Hakim, et al.
Published: (2014-01-01)

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
by: Patruno Savino FA, et al.
Published: (2002-08-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

Hematological Side Effects During Combination Therapy With Interferon and Ribavirin In Chronic Hepatitis C
by: Komal Owais
Published: (2015-06-01)

The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patients
by: Eman El-Ahwany, et al.
Published: (2016-02-01)

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
by: Tujana Boldanova, et al.
Published: (2017-06-01)

Treatment of hepatitis C virus infection: From therapy with interferon to direct-acting antivirals
by: Laura Lopera, et al.
Published: (2023-01-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha
by: Andréa Marques Vieira da Silva, et al.
Published: (2021-07-01)

The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients
by: Claudia da Silva, et al.

PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON ALPHA (PEG-IFN α) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE 1.
by: Krasimir Antonov, et al.
Published: (2011-12-01)

Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit
by: Irene Vafiadis, et al.
Published: (2013-07-01)

Association of SNPs In Interferon Receptor Genes in Chronic Hepatitis C with Response to Combined Therapy of Interferon and Ribavirin
by: Zohreh Heidari, et al.
Published: (2014-10-01)

Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis
by: Ni An, et al.
Published: (2022-11-01)

A Human and Rhesus Macaque Interferon-Stimulated Gene Screen Shows That Over-Expression of <i>ARHGEF3/XPLN</i> Inhibits Replication of Hepatitis C Virus and Other Flavivirids
by: Connor G. G. Bamford, et al.
Published: (2022-07-01)

Interferon lambda: opportunities, risks and uncertainties in the fight against HCV
by: Stephen M Laidlaw, et al.
Published: (2014-10-01)

Prevalence of Hepatitis C Virus (HCV) Genotypes in Rawalpindi and Islamabad Region
by: Andleeb Afzal
Published: (2017-06-01)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
by: Vincenzo Messina, et al.
Published: (2020-12-01)

Association of HCV Load and Interferon Therapeutic Response with Gender in Hepatitis C Patients Presenting to a Tertiary Care Health Facility, Rawalpindi
by: Mahnoor Javed Janjua
Published: (2018-11-01)

Treatment Efficacy of Sofosbuvir and Ribavirin Combination at Two Weeks in Chronic Hepatitis C
by: Aqsa Naseer
Published: (2017-12-01)

Liver cirrhosis and hepatic stellate cells Cirrose hepática e células estreladas do figado
by: Daniel Ferracioli Brandão, et al.
Published: (2006-01-01)

The interferons : characterization and application /
by: Meager, Anthony
Published: (2006)

Hepatitis C virus resistance to interferon therapy: an alarming situation
by: Kanwal Sobia, et al.
Published: (2014-12-01)

Polineuropatia desmielinizante inflamatória crônica pós-tratamento com interferon peguilado alfa 2b em um paciente co-infectado HIV/HCV: relato de caso Chronic inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alpha 2b in a patient with HIV/HCV coinfection: case report
by: Bil Randerson Bassetti, et al.
Published: (2010-02-01)

Clinical, demographic and epidemiological characteristics of patients with hepatitis B followed at a university hospital in southeastern Brazil: predominance of HBeAg negative cases
by: Silvana Gama Florencio Chachá, et al.
Published: (2011-02-01)

Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C Group Study
by: Francesca Romana Ponziani, et al.
Published: (2012-05-01)

HCV-induced autophagy and innate immunity
by: Jiyoung Lee, et al.
Published: (2024-02-01)

HCV carriers with normal aminotransferase levels: “normal” does not always mean “healthy”
by: Claudio Puoti
Published: (2013-04-01)

Association between Hepatitis C Virus Infection and Esophageal Cancer: An Asian Nationwide Population-Based Cohort Study
by: Yin-Yi Chu, et al.
Published: (2021-05-01)

Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice
by: Luisa Cavalletto, et al.
Published: (2008-01-01)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
by: Pellicelli Adriano M, et al.
Published: (2012-11-01)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
by: Megen C. Wittling, et al.
Published: (2021-01-01)